Study title: Bioavailability of Konakino MM, Ro 01-6722/130, oral and parenteral in mature neonates at birth (>2000g) and the evolution of vitamin K1 plasma level in breastfed babies
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Digestive System Diseases [C06] | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: PHYTOMENADION | |||||
ATC code: B02BA01 | |||||
Document link: | |||||
Document date: | |||||
Study number: B-115'048 | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | Y | - | - | - |